Use of Nanotechnology to Develop Multi-Drug Inhibitors for Cancer Therapy

Raghavendra Gowda^1,5,6,7, Nathan R. Jones¹, Shubhadeep Banerjee^1,5,6 and Gavin P. Robertson^{1,2,3,4,5,6,7*}

¹Department of Pharmacology, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA

²Department of Pathology, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA

³Department of Dermatology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA

⁴Department of Surgery, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA

⁵Penn State Hershey Melanoma Center, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA

⁶Penn State Melanoma Therapeutics Program, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA

⁷The Foreman Foundation for Melanoma Research, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA